Transcription of NEW ZEALAND DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
Example: bachelor of science
NEW ZEALAND DATA SHEET - Medsafe
Vidaza ( azacitidine ) 100 mg Powder for Injection NZ data SHEET Celgene 29 January 2018 (CCDS V12) Page 1 of 16 NEW ZEALAND data SHEET 1 PRODUCT NAME Vidaza ( azacitidine ) 100 mg Powder for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 100 mg azacitidine . For the full list of excipients, see section 3 PHARMACEUTICAL FORM Presentation The finished product is supplied in a sterile form for reconstitution as a suspension for subcutaneous injection or reconstitution as a solution with further dilution for intravenous infusion. Vials of Vidaza contain 100 mg of azacitidine and 100 mg mannitol as a white to off-white, sterile lyophilised powder. Description azacitidine is a white to off-white solid. It is insoluble in acetone, ethanol, and methyl ethyl ketone.
Vidaza® (azacitidine) 100 mg Powder for Injection – NZ Data Sheet Celgene V1.10 – 29 January 2018 (CCDS V12) Page 1 of 16 NEW ZEALAND DATA SHEET 1 PRODUCT NAME Vidaza® (azacitidine) 100 mg Powder for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: